IBIO

IBIO INC

IBIO·451033708·US·Common Stock·Healthcare - Biotechnology-13D/G

IBIO (IBIO INC) is held by 28 institutional investors as of Q1 2026. Largest holders: MILLENNIUM MANAGEMENT LLC ($2.9M), VANGUARD CAPITAL MANAGEMENT LLC ($2.1M), BALYASNY ASSET MANAGEMENT L.P. ($1.9M). Net institutional sentiment: Mixed.

28
Holders
Avg rating(6 Elite)
$15.2M
Total Value
63% (34)
Fund Consensus
19 buying - 11 selling
IBIOSmart Money Verdict
View all
Held by 28 funds
6 elite
Who's Trading
ActivistSISirenia Capital Management LP9.9%May 15, 2026
ActivistCACormorant Asset Management, LP10.0%May 15, 2026
ActivistECEcoR1 Capital, LLC4.6%May 15, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.0%May 15, 2026
ActivistAAAffinity Asset Advisors, LLC10.0%May 14, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.5.7%May 12, 2026
InsiderBMBanjak MarcBuy $3KMar 26, 2026
InsiderBMBanjak MarcBuy $21KMar 26, 2026
InsiderDFDuran FelipeBuy $50KMar 19, 2026
InsiderBMBrenner MartinBuy $25KMar 19, 2026
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.5M$2.9M0.0%-43.87%
36
New
1.1M$2.1M0.0%-43.87%
36
Decreased
1M(-7.8%)$1.9M0.0%-11.27%
0
New
956,429$1.8M0.0%-43.87%
36
Increased
620,602(+411.7%)$1.2M0.0%-39.56%
41
New
412,725$784,1780.0%-43.87%
34
Decreased
408,858(-10.4%)$776,8300.0%-11.70%
0
Increased
388,554(+95.9%)$738,2530.0%-31.04%
39
Increased
387,567(+74.1%)$736,6020.0%-32.55%
25
Increased
290,413(+150.8%)$551,7850.0%-34.33%
27
New
205,015$389,5290.0%-43.87%
33
New
200,212$380,4030.0%-43.87%
36
Increased
141,199(+93.7%)$268,2780.0%-45.27%
25
Increased
131,215(+207.1%)$249,3090.0%-51.00%
25
Increased
77,324(+91.8%)$146,9160.0%-42.65%
24
Increased
62,451(+68.7%)$118,6570.0%-28.41%
33
Increased
30,937(+12.1%)$58,7800.0%-17.01%
16
Decreased
12,180(-2.5%)$23,1420.0%-11.70%
0
New
5,460$10,3740.0%-43.87%
26
New
3,891$7,0000.0%-43.87%
25

Showing 1-20 of 34

1 / 2

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used